# TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tribute-a-phase-iii-trial-of-erlotinib-hydrochloride-osi-774-combined-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Roy S. Herbst,Diane Prager,Róbert Hermann,L. Fehrenbacher,Bruce E. Johnson,Alan Sandler,Mark G. Kris,Hai T. Tran,Pam Klein,Xin Li,David A. Ramies,David H. Johnson,Vincent A. Miller |
| Citations | 1,499 |
| DOI | 10.1200/jco.2005.02.840 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.02.840?role=tab |
| OpenAlex ID | https://openalex.org/W2162724777 |
| PMID | 16043829 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Mark G. Kris](https://scholariq.org/researchers/mark-g-kris/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.